Watch out for these penny stocks locked in the upper circuit on November 01
Watch out for these penny stocks locked in the upper circuit on November 01
Sensex and Nifty are experiencing modest declines of 0.16 per cent and 0.19 per cent, respectively.
In the broader market, a positive sentiment prevails, with approximately 1,903 stocks advancing compared to 1577 stocks declining.
Rs 22,100 crore order book and FIIs increase stake: This automotive giant reports impressive quarter and bags two big orders!
Shares of the company gained more than 10 per cent in the last six months.
Shares of the company gained more than 10 per cent in the last six months.
Ashish Dhawan earns Rs 1,88,57,30,000 from this mid-cap stock in one year!
Ace investor Ashish Dhawan with a holding of 31,00,000 shares of this stock in his portfolio gained Rs 1,88,57,30,000 within one year.
During just one year, this multibagger stock surged by Rs 608.30, marking a remarkable gain of 192.96 percent.
Watch out for these penny stocks locked in the upper circuit on September 18
Sensex experienced a modest decline of 0.06 per cent, while the Nifty saw a slight dip of 0.09 per cent
Within the market segments, the Nifty Midcap segment showed a small retreat of 0.17 per cent, whereas the Nifty Smallcap managed to secure a marginal gain of 0.06 per cent.
Rs 30,500 crore order book: This multibagger infrastructure company bags new orders worth Rs 1,042 crore; hits fresh 52-week high!
Shares of the company grew by more than 22 per cent in the last six months.
Shares of the company grew by more than 22 per cent in the last six months.
This mid-cap tech company gives 1,700 per cent in just 3 years!
The company has delivered exceptional returns of 112 per cent over the past year and returns of 1,706 per cent over the past 3 years.
The company has a ROCE of 30.6 per cent and a ROE of 25.9 per cent. Moreover, the company has been maintaining a healthy dividend payout ratio of 25.6 per cent.
Action seen in this pharmaceuticals stock; acquisition worth Rs 106 crore!
The stock has witnessed significant buying activity as it has given returns of more than 55 per cent in just one year.
The company has reported positive numbers in financial results.
Shares surge 10 per cent to hit 52-week high as board mulls voluntary delisting!
A board meeting will be held to discuss a proposal to delist its equity shares.
In 2018 April a Rs 4,000 crore IPO had received a poor response and it was undersubscribed by 78 per cent during the three-day bidding process.
Heavy buying seen: Back-to-back 52-week high in this multibagger mid-cap stock!
The stock has surged more than 280 per cent in the last 3 years.
Astonishingly, the PAT surged 277.87 per cent from March 2022 quarter to report Rs 427 crore.
This civil construction company receives order worth Rs 50.67 crore from Navodaya Vidyalaya Samiti!
The company has a ROCE of 20.8 per cent with a ROE of 19.8 per cent.
The company has a healthy dividend payout ratio of 44.4 per cent.
This mid-cap multibagger Pharma company signs MOA with IIT Kanpur for novel gene therapy assets!
The company delivered exceptional returns of 251 per cent over the past 3 years.
The company delivered exceptional returns of 251 per cent over the past 3 years, while over the past 5 years, it provided remarkable returns of 242 per cent.
This multibagger tech company partners with FundMore to deliver compliance automation solutions for mortgage lenders in Canada!
The company has a ROCE of 31.6 per cent and a ROE of 25.1 per cent.
The company gave great returns of 36 per cent over the past 1 year and stellar returns of 235 per cent over the past 3 years. Moreover, it has a healthy dividend payout ratio of 40.1 per cent.